IRIS
DAGNA, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.493
NA - Nord America 11.213
AS - Asia 10.372
SA - Sud America 2.197
Continente sconosciuto - Info sul continente non disponibili 865
AF - Africa 232
OC - Oceania 38
AN - Antartide 1
Totale 38.411
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.604
RU - Federazione Russa 7.047
SG - Singapore 3.601
CN - Cina 3.393
BR - Brasile 1.778
IT - Italia 1.628
RO - Romania 1.138
SE - Svezia 1.135
HK - Hong Kong 1.115
VN - Vietnam 924
DE - Germania 641
FR - Francia 514
GB - Regno Unito 395
CA - Canada 304
BD - Bangladesh 299
IN - India 246
FI - Finlandia 235
AR - Argentina 175
NL - Olanda 159
MX - Messico 153
AT - Austria 115
JP - Giappone 115
PL - Polonia 115
TR - Turchia 101
ID - Indonesia 98
ZA - Sudafrica 93
ES - Italia 89
IQ - Iraq 68
EC - Ecuador 58
CO - Colombia 55
IE - Irlanda 54
PK - Pakistan 53
PH - Filippine 48
MY - Malesia 41
UA - Ucraina 41
LT - Lituania 40
VE - Venezuela 39
JM - Giamaica 35
MA - Marocco 35
SA - Arabia Saudita 32
AE - Emirati Arabi Uniti 29
AU - Australia 29
PY - Paraguay 27
UZ - Uzbekistan 27
PE - Perù 25
CL - Cile 23
BE - Belgio 22
EG - Egitto 22
IL - Israele 22
NP - Nepal 22
TN - Tunisia 20
HN - Honduras 19
IR - Iran 19
KE - Kenya 19
JO - Giordania 18
NI - Nicaragua 18
DO - Repubblica Dominicana 16
NO - Norvegia 13
CR - Costa Rica 12
CH - Svizzera 11
GR - Grecia 11
GT - Guatemala 11
MD - Moldavia 11
TH - Thailandia 11
TT - Trinidad e Tobago 11
UY - Uruguay 11
AZ - Azerbaigian 10
DZ - Algeria 10
PT - Portogallo 10
BG - Bulgaria 9
KR - Corea 9
BH - Bahrain 8
HU - Ungheria 8
KZ - Kazakistan 8
NZ - Nuova Zelanda 8
SN - Senegal 8
CZ - Repubblica Ceca 7
PA - Panama 7
TW - Taiwan 7
XK - ???statistics.table.value.countryCode.XK??? 7
DK - Danimarca 6
LV - Lettonia 6
BO - Bolivia 5
BW - Botswana 5
EU - Europa 5
GE - Georgia 5
LU - Lussemburgo 5
MK - Macedonia 5
BY - Bielorussia 4
CY - Cipro 4
ET - Etiopia 4
KW - Kuwait 4
LB - Libano 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
AL - Albania 3
AM - Armenia 3
BS - Bahamas 3
CU - Cuba 3
Totale 37.490
Salva come PNG Salva come JPEG
Città #
Dallas 2.498
Singapore 1.779
Moscow 1.399
Ashburn 1.263
San Jose 1.114
Hong Kong 1.087
Shanghai 662
Council Bluffs 489
Beijing 483
New York 472
Hefei 436
Milan 413
Lauterbourg 374
Ho Chi Minh City 332
Los Angeles 297
Lawrence 278
Princeton 278
Santa Clara 219
Hanoi 197
Munich 197
Boardman 185
São Paulo 178
Nuremberg 152
Rome 129
Helsinki 128
Orem 116
Denver 94
Warsaw 93
Montreal 91
London 86
Tokyo 77
Atlanta 75
Brooklyn 74
Guangzhou 70
Poplar 69
Rio de Janeiro 69
Chicago 67
Phoenix 64
Chennai 63
Frankfurt am Main 62
Seattle 62
Johannesburg 61
Mexico City 61
Toronto 58
Boston 55
Turku 54
Houston 53
Amsterdam 52
Dublin 49
Lappeenranta 49
Stockholm 47
Manchester 46
Pune 43
Ankara 42
Vienna 42
Da Nang 41
Washington 41
Mumbai 37
Belo Horizonte 36
Buffalo 36
Falkenstein 33
Haiphong 33
San Francisco 31
Brasília 30
Cesano Boscone 30
Omaha 27
Tianjin 27
Querétaro 26
Istanbul 25
Shenzhen 25
Curitiba 24
Florence 24
Tashkent 24
The Dalles 24
Xi'an 24
Ancona 23
Columbus 23
Jakarta 23
Bologna 22
Lahore 22
New Delhi 22
Kuala Lumpur 21
Salvador 21
Turin 21
Campinas 20
Charlotte 20
City of London 20
Hải Dương 20
Bogotá 19
Cape Town 19
Porto Alegre 19
Baghdad 18
Brussels 18
Changsha 18
Genoa 18
Hangzhou 18
The Bronx 18
Bexley 17
Biên Hòa 17
Brescia 17
Totale 18.075
Salva come PNG Salva come JPEG
Nome #
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study 571
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 464
Intercalated Disc Abnormalities Are Linked to Arrhythmias in Inflammatory Cardiomyopathy 446
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 395
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 350
The association between body mass index and fibromyalgia severity: Data from a cross-sectional survey of 2339 patients 335
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study 308
Monkeypox in a patient with undifferentiated connective tissue disease 253
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 236
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 221
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 212
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 209
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 204
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients 187
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 184
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 180
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 178
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 175
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 175
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 168
Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis 166
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 165
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 160
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 156
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 156
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 156
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 154
Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support 153
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 153
Biobanking for COVID-19 research 149
Virus-encoded chemokines, chemokine receptors and chemokine-binding proteins: new paradigms for future therapy 147
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 147
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 146
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 142
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 138
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 137
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 137
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 137
Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature 133
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis 132
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis 131
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 131
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients 131
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 130
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 130
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 130
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 129
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 127
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 125
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 125
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 124
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 124
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 124
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 124
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 123
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 122
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 122
[Cardiovascular involvement in Erdheim-Chester syndrome: clinical and therapeutic implications]. FT Coinvolgimento cardiovascolare nella sindrome di Erdheim-Chester: aspetti clinici e terapeutici. 121
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 121
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis 120
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 120
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 120
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 120
Prone positioning in awake COVID-19 patients: a systematic review and meta-analysis 119
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 118
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 118
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 118
Urgent manifestations of immunoglobulin G4-related disease 118
Therapeutic strategies for primary heart involvement in systemic sclerosis 117
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients 117
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease 117
A Novel Histiocytosis With Synovial and Skin Involvement 117
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 116
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 116
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy 116
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 116
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 115
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 115
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 114
Testosterone in males with COVID-19: A twelve-month cohort study 114
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study 114
Drug retention rates of biological agents in adult onset Still's disease 114
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 113
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis 113
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 113
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 112
C3-glomerulopathy and MGUS: The skin beyond the kidney 112
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 112
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 111
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands 110
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 110
Two months quality of life of COVID-19 invasively ventilated survivors; an Italian single-center study 110
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients 110
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort 109
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 109
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series 109
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis 109
Assessing the role of pentraxin-3 in Takayasu's arteritis. Comment on: Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up. Alibaz-Oner F. et al 109
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 108
Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis 108
Totale 15.485
Salva come PNG Salva come JPEG
Categoria #
all - tutte 202.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022428 0 0 101 78 26 27 33 26 42 37 30 28
2022/20232.175 652 435 141 21 36 244 220 209 102 39 40 36
2023/20242.244 79 135 231 200 184 373 118 204 18 92 210 400
2024/20257.670 639 146 220 243 291 550 2.019 711 1.014 686 486 665
2025/202624.010 1.583 2.171 2.331 2.866 1.780 662 2.025 1.662 6.132 1.253 731 814
2026/20271.653 733 920 0 0 0 0 0 0 0 0 0 0
Totale 38.411